BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 27607340)

  • 1. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I; Mammen AL
    Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
    Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
    Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O
    Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
    Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune-Mediated Necrotizing Myopathy].
    Uruha A
    Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrosis in anti-SRP
    Allenbach Y; Arouche-Delaperche L; Preusse C; Radbruch H; Butler-Browne G; Champtiaux N; Mariampillai K; Rigolet A; Hufnagl P; Zerbe N; Amelin D; Maisonobe T; Louis-Leonard S; Duyckaerts C; Eymard B; Goebel HH; Bergua C; Drouot L; Boyer O; Benveniste O; Stenzel W
    Neurology; 2018 Feb; 90(6):e507-e517. PubMed ID: 29330311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
    Arouche-Delaperche L; Allenbach Y; Amelin D; Preusse C; Mouly V; Mauhin W; Tchoupou GD; Drouot L; Boyer O; Stenzel W; Butler-Browne G; Benveniste O
    Ann Neurol; 2017 Apr; 81(4):538-548. PubMed ID: 28224701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
    Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
    Basharat P; Christopher-Stine L
    Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.